These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21197446)

  • 41. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
    Minter MR; Taylor JM; Crack PJ
    J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uptake of raft components into amyloid β-peptide aggregates and membrane damage.
    Sasahara K; Morigaki K; Mori Y
    Anal Biochem; 2015 Jul; 481():18-26. PubMed ID: 25908557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.
    Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F
    J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Membrane rafts in Alzheimer's disease beta-amyloid production.
    Vetrivel KS; Thinakaran G
    Biochim Biophys Acta; 2010 Aug; 1801(8):860-7. PubMed ID: 20303415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
    Butterfield DA; Castegna A; Lauderback CM; Drake J
    Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular cholesterol homeostasis and Alzheimer's disease.
    Chang TY; Yamauchi Y; Hasan MT; Chang C
    J Lipid Res; 2017 Dec; 58(12):2239-2254. PubMed ID: 28298292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
    Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
    Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Commentary: Abeta N- Terminal Isoforms: Critical contributors in the course of AD pathophysiology.
    Tekirian TL
    J Alzheimers Dis; 2001 Apr; 3(2):241-248. PubMed ID: 12214065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons.
    Umeda T; Ramser EM; Yamashita M; Nakajima K; Mori H; Silverman MA; Tomiyama T
    Acta Neuropathol Commun; 2015 Aug; 3():51. PubMed ID: 26293809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
    Tampellini D; Gouras GK
    Front Aging Neurosci; 2010; 2():. PubMed ID: 20725518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amyloid beta-peptide: the inside story.
    Tseng BP; Kitazawa M; LaFerla FM
    Curr Alzheimer Res; 2004 Nov; 1(4):231-9. PubMed ID: 15975052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition.
    Harris-White ME; Frautschy SA
    Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):469-80. PubMed ID: 16266282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of membrane interaction and aggregation of amyloid β-peptide on lipid mobility and membrane domain structure.
    Sasahara K; Morigaki K; Shinya K
    Phys Chem Chem Phys; 2013 Jun; 15(23):8929-39. PubMed ID: 23515399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease.
    Liu CC; Zhao N; Yamaguchi Y; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
    Sci Transl Med; 2016 Mar; 8(332):332ra44. PubMed ID: 27030596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glial Draper Rescues Aβ Toxicity in a
    Ray A; Speese SD; Logan MA
    J Neurosci; 2017 Dec; 37(49):11881-11893. PubMed ID: 29109235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Alzheimer's disease amyloid-β peptide affects the size-dynamics of raft-mimicking Lo domains in GM1-containing lipid bilayers.
    Staneva G; Puff N; Stanimirov S; Tochev T; Angelova MI; Seigneuret M
    Soft Matter; 2018 Dec; 14(47):9609-9618. PubMed ID: 30457145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.